Peter G. Traber
Overview
Peter G. Traber received an average of $2M in total compensation, including $309K in salary, at SELECTA BIOSCIENCES between 2020 and 2021. Peter Traber also received an average of $2M at Galectin Therapeutics from 2011 to 2017.
- 2021
- 2020
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
SELECTA BIOSCIENCESChief Medical Officer
SELECTA BIOSCIENCESChief Medical Officer
Galectin TherapeuticsChief Executive Officer & President
Galectin TherapeuticsChief Executive Officer & President
Galectin TherapeuticsChief Executive Officer & President
Galectin TherapeuticsChief Executive Officer & President
Galectin TherapeuticsChief Executive Officer & President
Galectin TherapeuticsChief Executive Officer & President
Galectin TherapeuticsChief Executive Officer & President
Source: SEC filings on May 3, 2022, April 22, 2022, April 11, 2018, November 7, 2017, November 10, 2016, April 8, 2015, and April 12, 2013.
Related executives
We found 23 more executives who work or worked at SELECTA BIOSCIENCES and Galectin Therapeutics.
Joel Lewis
Galectin Therapeutics
Chief Executive Officer
Pol Boudes
Galectin Therapeutics
Chief Medical Officer
Jack Callicutt
Galectin Therapeutics
Chief Financial Officer
Carsten Brunn
SELECTA BIOSCIENCES
Chief Executive Officer
Kevin Tan
SELECTA BIOSCIENCES
Chief Financial Officer
Takashi Kishimoto
SELECTA BIOSCIENCES
Chief Scientific Officer
Lloyd Johnston
SELECTA BIOSCIENCES
Chief Operations Officer
Bradford Dahms
SELECTA BIOSCIENCES